Our Values
Innovation, Collaboration, and Hope
Outsmarting cancer, together
Omico is a nationwide network of research and treatment centres that facilitates, supports and promotes clinical trials in genomic cancer medicine. Central to this is the use of molecular screening for the prevention and treatment of cancer.
Our Mission
Recent News
How cancer develops resistance to treatment
The cells of the human body are constantly dividing, and each time need to copy a three billion-letter DNA code with high precision to ensure cell survival. The same is not true for cancers, researchers have discovered.
A reflection on cancer
Professor David Thomas provides a glimpse of what the future of cancer research could look like.
Australian Government & Roche co-fund the ‘ASPiRATION’ lung cancer study
Roche Australia, in partnership with the Australian Government announced a jointly funded a genomic profiling research project called ‘ASPiRATION’ for 1,000 Australians with newly diagnosed metastatic, non-squamous, non-small cell lung cancer.